Pharmaceutical products

Image credit: Dyadic FB

Company News

Animal-Free Protein & Enzyme Producer Dyadic Applied BioSolutions to Receive Milestone Payments Following Commercial Progress

Global biotechnology company Dyadic Applied BioSolutions has announced the achievement of additional milestone payments in its collaborations with Proliant Health & Biologicals and Inzymes ApS. The company, which produces precision-engineered, animal-free proteins and enzymes for commercial applications, has also provided updates on its business transformation and commercial progress. In food and nutrition, Dyadic has announced the signing of a term sheet for the development of non-animal human alpha-lactalbumin for use …

more

Dyadic develops recombinant animal-free bovine serum albumin that can be used i the cultivated meat industry

Image credit: Dyadic International

General

Dyadic’s Revolutionary Animal-Free Bovine Serum Albumin to Solve Costs and Ethical Challenges of Cultivated Meat and Pharmaceuticals

Biotechnology company Dyadic International, Inc. (NASDAQ: DYAI) announces that independent analysis has confirmed that its revolutionary animal-free bovine serum albumin is structurally identical to commercial animal albumin, opening new commercialization opportunities.  Bovine serum albumin (BSA) is universal in the pharmaceutical industry. It has applications for human therapeutics, cell culture media, diagnostic test kits, PCR, vaccine development, R&D, and more. Additionally, it is frequently used as a component of the cell …

more